News / Edinburgh & East
Givinostat can slow the progression of Duchenne muscular dystrophy and is now available to some patients via an early access programme.
Families of children living with a progressive muscle-wasting condition have welcomed the roll-out of a new drug that could slow the impact of the disease. More